2-Naphthalenecarboxylicacid,4-(2,2-dimethyl-1-oxobutoxy)-3,4,4a,5,6,7-hexahydro-6-methyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-,[4S-[4a,4ab,5b(2S,4S),6b]]-(9CI) (125206-31-7)

Identification
Name:	2-Naphthalenecarboxylicacid,4-(2,2-dimethyl-1-oxobutoxy)-3,4,4a,5,6,7-hexahydro-6-methyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-,[4S-[4a,4ab,5b(2S,4S),6b]]-(9CI)
Synonyms:	[4S-[4a,4ab,5b(2S,4S),6b]]-4(2,2-Dimethyl-1-oxobutoxy)-3,4,4a,5,6,7-hexahydro-6-methyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-2-naphthalenecarboxylic Acid;6Carboxy Simvastatin;([4S-[4 ,4a ,5 (2S,4S),6 ]]-4(2,2-Dimethyl-1-oxobutoxy)-3,4,4a,5,6,7-hexahydro-6-methyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-2-naphthalenecarboxylic Acid);[4S-[4a,4a,5(2S,4S),6]]-4(2,2-Dimethyl-1-oxobutoxy)-3,4,4a,5,6,7-hexahydro-6-methyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-2-naphthalenecarboxylic Acid
CAS:	125206-31-7
Molecular Formula:	C25H36 O7
Molecular Weight:	0
InChI:	InChI=1/C25H36O7/c1-5-25(3,4)24(30)32-20-11-16(23(28)29)10-15-7-6-14(2)19(22(15)20)9-8-18-12-17(26)13-21(27)31-18/h6-7,10,14,16-20,22,26H,5,8-9,11-13H2,1-4H3,(H,28,29)/t14-,16?,17+,18+,19-,20?,22-/m0/s1
Molecular Structure:
Properties
Refractive index:	1.55
Usage:	A HMG-COA reductase inhibitor; useful as anticholesteramic
Safety Data

2-Naphthalenecarboxylicacid,4-(2,2-dimethyl-1-oxobutoxy)-3,4,4a,5,6,7-hexahydro-6-methyl-5-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-,[4S-[4a,4ab,5b(2S*,4S*),6b]]-(9CI) (125206-31-7)